Retinoic Acid Action in Cumulus Cells: Implications for Oocyte Development and In Vitro Fertilization
Neil Sidell1, Augustine Rajakumar1
1Department of Gynecology & Obstetrics, Emory University School of Medicine, Atlanta, GA 30322, USA.
International Journal of Molecular Sciences
|February 10, 2024
Summary
Retinoic acid (RA) in cumulus granulosa cells (CGCs) may indicate oocyte quality for in vitro fertilization (IVF). High RA levels in follicular fluid correlate with better embryo development, suggesting RA as a potential non-invasive biomarker for selecting viable oocytes.
Area of Science:
- Reproductive Biology
- Cellular Signaling
- Biomarker Discovery
Background:
- Selecting optimal oocytes is crucial for successful in vitro fertilization (IVF).
- Current methods for assessing oocyte quality are often invasive or have limited success.
- Retinoic acid (RA) is known to positively influence oocyte maturation and function.
Purpose of the Study:
- To investigate the causal role of retinoic acid (RA) in cumulus granulosa cells (CGCs) for oocyte competence.
- To explore the potential of CGC RA as a non-invasive biomarker for oocyte quality in IVF.
- To examine the regulatory role of RA on connexin-43 (Cx43) and its impact on oocyte development.
Main Methods:
- Analysis of follicular fluid (FF) RA concentrations in relation to embryo quality.
- Investigating the effect of RA on Cx43 expression and gap junction intercellular communication (GJIC) in CGCs.
- Evaluating the association between CGC RA levels and oocyte developmental competence.
Main Results:
- High FF RA concentrations correlate with the development of highest quality embryos.
- RA up-regulates GJIC in the cumulus-oocyte complex via non-genomic mechanisms involving Cx43 dephosphorylation.
- CGCs are identified as the primary source of follicle RA synthesis.
Conclusions:
- CGC RA levels show promise as a non-invasive biomarker for selecting high-quality oocytes in IVF.
- RA's action on Cx43 in CGCs plays a causal role in oocyte competency.
- Targeting Cx43 with retinoids may offer novel therapeutic strategies for improving IVF outcomes.
Related Concept Videos
Oogenesis
1.5K
Oogenesis, the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is...
1.5K
Meiosis II
183.4K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
183.4K
In Vitro Fertilization
265
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
265
Folliculogenesis
771
Folliculogenesis is the development of ovarian follicles, the specialized structures within the ovarian cortex where oogenesis, or egg development, occurs. This process is essential for female reproductive health and begins during fetal development when primordial follicles are formed. Each primordial follicle comprises a primary oocyte in the center, surrounded by a single layer of squamous pre-granulosa cells. These follicles remain dormant in late prophase I of meiosis until triggered by...
771


